Related Experiment Video

Updated: Aug 10, 2026

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
10:25

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury

Published on: August 30, 2011

18.2K

Cardiorenal Syndrome: A Literature Review

Abimbola O Ajibowo1, Okelue E Okobi2,3, Erhieyovbe Emore4

  • 1Internal Medicine, Lugansk Medical University, Lugansk, UKR.

Cureus
|August 2, 2023
PubMed

Insights

Cardiorenal syndrome (CRS) involves heart and kidney dysfunction. Biomarkers are key for early diagnosis, prognosis, and managing this complex condition.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarker Research

Background:

  • Cardiorenal syndrome (CRS) describes the bidirectional relationship between cardiac and renal dysfunction.
  • Hemodynamic and non-hemodynamic factors critically influence CRS development and progression.
  • Understanding CRS is vital due to its impact on acute and chronic organ damage.

Purpose of the Study:

  • To review the clinical significance of biomarkers in diagnosing Cardiorenal Syndrome.
  • To explore the role of biomarkers in predicting prognosis for CRS patients.
  • To discuss the application of biomarkers in managing Cardiorenal Syndrome.

Main Methods:

  • Comprehensive literature review focusing on Cardiorenal Syndrome.
  • Analysis of studies investigating hemodynamic and non-hemodynamic factors in CRS.
  • Evaluation of biomarker utility in clinical settings for CRS.

Main Results:

  • Biomarkers aid in the early detection of Cardiorenal Syndrome.
  • Specific biomarkers correlate with prognosis and disease severity in CRS.
  • Neurohormonal and inflammatory markers are significant in CRS pathophysiology.

Conclusions:

  • Biomarkers are essential tools for the diagnosis, prognosis, and management of Cardiorenal Syndrome.
  • Further research is needed to advance the clinical management of CRS.
  • Early identification of CRS through biomarkers can lead to timely interventions.

Keywords:
cardio-renalcardio-renal cascadecardiorenal syndromecardiorenal syndrome reviewcardiorenal syndrome types

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.7K
Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock07:48

Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock

Published on: October 28, 2022

1.2K

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...